Voriconazole inhibits biofilm formation in different speciesof the genus Candida

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 10, 2012, Pages 2418-2423

  Valentin A ^a   Canto E ^b   Peman J ^b   Martinez J P ^c  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antifungal agents; C. orthopsilosis; Candidaemia; Surfaces

Indexed keywords

VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; BIOFILM FORMATION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN;

EID: 84866597111     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks242     Document Type: Article

References (34)

1. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002; 15: 167-93.
2. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-63.
3. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-67.
4. Kumamoto CA. Candida biofilms. Curr Opin Microbiol 2002; 5: 608-11.
5. Uppuluri P, Pierce CG, López-Ribot JL. Candida albicans biofilm formation and its clinical consequences. Future Microbiol 2009; 4: 1235-7.
6. Ramage G, Wickes BL, Lopez-Ribot JL. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am Clin Lab 2001; 20: 42-4.
7. Jabra-Rizk MA, Falkler WA, Meiller TF. Fungal biofilms and drug resistance. Emerg Infect Dis 2004; 10: 14-9.
8. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000; 46: 397-403.
9. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006; 50: 3839-46.
10. Perumal P, Mekala S, Chaffin WL. Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents Chemother 2007; 51: 2454-63.
11. Ramage G, Bachmann S, Patterson TF et al. Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 2002; 49: 973-80.
12. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 503-35.
13. Kuhn DM, George T, Chandra J et al. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-80.
14. Melo AS, Bizerra FC, Freymüller E et al. Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex. Med Mycol 2011; 49: 253-62.
15. Uppuluri P, Srinivasan A, Ramasubramanian A et al. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother 2011; 55: 3591-3.
16. Mukherjee PK, Chandra J, Kuhn DM et al. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003; 71: 4333-40.
17. Nett J, Lincoln L, Marchillo K et al. Putative role of b-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 2007; 51: 510-20.
18. Bachmann SP, VandeWalle K, Ramage G et al. In vitro activity of caspofungin against Candida albicans biofilms. Antimicrob Agents Chemother 2002; 46: 3591-6.
19. Soustre J, Rodier MH, Imbert-Bouyer S et al. Caspofungin modulates in vitro adherence of Candida albicans to plastic coated with extracellular matrix proteins. J Antimicrob Chemother 2004; 53: 522-5.
20. Alem MA, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004; 48: 41-7.
21. Bruzual I, Riggle P, Hadley S et al. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole. J Antimicrob Chemother 2007; 59: 441-50.
22. Derengowski LS, Pereira AL, Andrade AC et al. Propranolol inhibits Candida albicans adherence and biofilm formation on biotic and abiotic surfaces. Int J Antimicrob Agents 2009; 34: 619-21.
23. Raad II, Hachem RY, Hanna HA et al. Role of ethylene diamine tetra-acetic acid (EDTA) in catheter lock solutions: EDTA enhances the antifungal activity of amphotericin B lipid complex against Candida embedded in biofilm. Int J Antimicrob Agents 2008; 32: 515-8.
24. Pemán J, Salavert M, Cantón E et al. Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag 2006; 2: 129-58.
25. Valentín A, Cantón E, Pemán J et al. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Rev Iberoam Micol 2007; 24: 272-7.
26. Valentín A. Actividad in vitro de anfotericina B, caspofungina, anidulafungina y voriconazol sobre biopelículas de Candida spp. PhD Thesis. Universidad de Valencia, Espan{ogonek}a: Facultad de Farmacia, 2010.
27. Pemán J, Cantón E, Quindós G et al. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey. J Antimicrob Chemother 2012; 67: 1181-7.
28. Ramage G, Vande Walle K, Wickes BL et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 2001; 45: 2475-9.
29. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts-Third Edition: Approved Standard M27-A3. CLSI, Wayne, PA, USA, 2008.
30. Potera C. Forging a link between biofilms and disease. Science 1999; 283: 1837-9.
31. Tumbarello M, Posteraro B, Trecarichi EM et al. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007; 45: 1843-50.
32. Katragkou A, Chatzimoschou A, Simitsopoulou M et al. Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms. Antimicrob Agents Chemother 2008; 52: 357-60.
33. Chandra J, Patel JD, Li J et al. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 2005; 71: 8795-801.
34. Klotz SA, Drutz DJ, Zajic JE. Factors governing adherence of Candida species to plastic surfaces. Infect Immun 1985; 50: 97-101.